KölscheTWillisonAGMeuthSG, et al. Ofatumumab-induced severe reactivation of psoriasis in a patient with multiple sclerosis. Mult Scler2024; 30: 1086–1088.
ErranteDBernardiDBiancoA, et al. Rituximab-related urticarial reaction in a patient treated for primary cutaneous B-cell lymphoma. Ann Oncol2006; 17(11): 1720–1721.
4.
CochranALSchuldtMMQuinnJM. Ofatumumab desensitization protocol: A case of refractory immune thrombocytopenic purpura. Cureus2023; 15(9): e46278.
5.
AliSBYusonCHissariaP. Rituximab hypersensitivity reactions and tolerance of ofatumumab therapy. Clin Exp Rheumatol2021; 39(3): 648–650.
